...
机译:10年关于归因于阶段IIII-VB鼻咽癌(NPC-9901和NPC-9902试验的组合分析)的同时辅助化疗的疗效和晚期毒性的疗效和晚期毒性的10年结果
Univ Hong Kong Hong Kong Hong Kong Peoples R China;
Tuen Mun Hosp Dept Clin Oncol Hong Kong Hong Kong Peoples R China;
Pamela Youde Nethersole Eastern Hosp Hong Kong Hong Kong Peoples R China;
Queen Elizabeth Hosp Hong Kong Hong Kong Peoples R China;
Univ Hong Kong Hong Kong Hong Kong Peoples R China;
Univ Hong Kong Hong Kong Hong Kong Peoples R China;
Pamela Youde Nethersole Eastern Hosp Hong Kong Hong Kong Peoples R China;
Sun Yat Sen Univ Ctr Canc Guangzhou Guangdong Peoples R China;
Princess Margaret Canc Ctr Ontario Canc Inst Toronto ON Canada;
Natl Canc Ctr Singapore Singapore Singapore;
Tuen Mun Hosp Dept Clin Oncol Hong Kong Hong Kong Peoples R China;
Queen Elizabeth Hosp Hong Kong Hong Kong Peoples R China;
Princess Margaret Canc Ctr Ontario Canc Inst Toronto ON Canada;
Natl Canc Ctr Singapore Singapore;
Univ Wisconsin Madison WI USA;
机译:10年关于归因于阶段IIII-VB鼻咽癌(NPC-9901和NPC-9902试验的组合分析)的同时辅助化疗的疗效和晚期毒性的疗效和晚期毒性的10年结果
机译:52LBA NPC-9902试验的最终报告,该报告通过并发辅助化疗和/或加速分级治疗T3-4N0-1M0鼻咽癌的治疗获益和晚期毒性
机译:NPC-9901试验关于T1-4N2-3M0鼻咽癌同时辅助化疗的治疗获益和晚期毒性的最终报告
机译:局部并发鼻咽癌同时诱导与同时化疗的疗效比较:倾向评分匹配分析
机译:>强度调节放疗的十年结果(IMRT)与化疗与IMRT在现实世界研究(RWD)中单独进行ICRT,同时鼻咽癌(RWD) P>